Certara’s Vaccine Simulator™ Accurately Predicted Optimal Timing Between Doses for COVID-19
July 23, 2021 17:30 ET
|
Certara
PRINCETON, N.J., July 23, 2021 (GLOBE NEWSWIRE) -- Certara, a global leader in biosimulation, today announced that its Vaccine Simulator accurately predicted that eight weeks was the optimal timing...
Medolife Rx Clinical Observations Demonstrates Effectiveness of Escozine in Complementary Use with COVID-19 Vaccines
July 08, 2021 08:30 ET
|
Quanta, Inc.
BURBANK, Calif., July 08, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Medolife Rx, Inc. ("Medolife"), a global integrated biopharmaceutical company with R&D, manufacturing, and consumer product...
ROSEN, A LEADING, LONGSTANDING, AND TOP RANKED LAW FIRM, Encourages Emergent BioSolutions Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – EBS
June 02, 2021 16:11 ET
|
The Rosen Law Firm PA
NEW YORK, June 02, 2021 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Emergent BioSolutions Inc. (NYSE: EBS) between April 24,...
COVID-19 Pipeline Diversifies as the COVID-19 Cases Soar and Demand for Effective Therapies Balloons | DelveInsight
June 01, 2021 20:20 ET
|
DelveInsight Business Research LLP
Los Angeles, USA, June 01, 2021 (GLOBE NEWSWIRE) -- COVID-19 Pipeline Diversifies as the COVID-19 Cases Soar and Demand for Effective Therapies Balloons | DelveInsight Efforts in clinical...
Four Cleveland Clinic Hospitals Not Administering COVID-19 Vaccine: Lucky Star Research
April 12, 2021 11:11 ET
|
Lucky Star Communications
CLEVELAND, April 12, 2021 (GLOBE NEWSWIRE) -- Four of Cleveland Clinic's 11 main health facilities in northeast Ohio are not currently administering the COVID-19 vaccine, according to research by...
UPDATE -- Dyadic Advancing Proprietary Owned COVID-19 vaccine candidate, DYAI-100, Towards Human Clinical Trial
March 29, 2021 08:30 ET
|
Dyadic International, Inc.
Advancing Dyadic’s proprietary owned COVID-19 vaccine candidate, DYAI-100, towards first-in-human Phase 1 clinical trial Engaged CR2O, a contract research organization, to manage and support further...
Meeting the Moment, Reflections One Year On: The American College of Medical Toxicology’s Response to the COVID-19 Pandemic
March 25, 2021 10:00 ET
|
American College of Medical Toxicology
Phoenix, AZ, March 25, 2021 (GLOBE NEWSWIRE) -- March 2021 marks the one-year anniversary of the World Health Organization’s official designation of the outbreak of the COVID-19 pandemic. The...
Dyadic and Medytox To Develop Vaccines Against COVID-19 Variants
March 23, 2021 09:00 ET
|
Dyadic International, Inc.
Expanding existing COVID-19 vaccine research collaboration which began in July 2020.Medytox and Dyadic to co-develop C1 enabled COVID-19 vaccines and/or boosters which will immunize people against two...
Dyadic and Medytox To Develop Vaccines Against COVID-19 Variants
March 22, 2021 08:30 ET
|
Dyadic International, Inc.
Expanding existing COVID-19 vaccine research collaboration which began in July 2020.Medytox and Dyadic to co-develop C1 enabled COVID-19 vaccines and/or boosters which will immunize people against two...
FLORIDA CANCER SPECIALISTS & RESEARCH INSTITUTE COLLABORATES WITH COUNTY HEALTH DEPARTMENTS TO PROVIDE COVID-19 VACCINES TO HIGH-RISK INDIVIDUALS
March 16, 2021 11:38 ET
|
Florida Cancer Specialists
Fort Myers, Fla., March 16, 2021 (GLOBE NEWSWIRE) -- In collaboration with county health departments throughout the state, Florida Cancer Specialists & Research Institute (FCS) is providing...